AU Wells, DM Hansell, MB Rubens, JB Cailes, CM Black and RM du Bois
Department of Radiology, Royal Brompton Hospital, London, United Kingdom.

Lone cryptogenic fibrosing alveolitis (CFA) is histologically identical to fibrosing alveolitis associated with systemic sclerosis (FASSc), but it has a much worse prognosis after matching for disease severity at presentation. Thin-section CT scanning (CT) provides a reproducible method of quantifying the morphologic extent of fibrosing alveolitis. The aim of this study was to gain insights into contrasting pathophysiologic mechanisms in the two diseases by comparing patterns of functional impairment after matching for extent of disease on CT, demographic factors, smoking history, and concurrent treatment. Patients with emphysema on CT (n = 16) and patients with FASSc with overt pulmonary hypertension (n = 5) were excluded; 111 patients were studied (CFA, n = 54; FASSc, n = 57). Patients with CFA were distinguished by more severe functional impairment and more extensive disease on CT (40.1 versus 22.1%, p < 0.00005). On multivariate analysis, patients with CFA had greater reduction in arterial P(O2) (p < 0.0005), wider AaP(O2) (p < 0.0005), greater oxygen desaturation on maximal exercise (p < 0.03), and higher dyspnea scores (p < 0.02) than did patients with FASSc after controlling for extent of disease on CT and other covariates. Measures of lung volume and gas transfer did not differ independently between CFA and FASSc. These findings persisted in subanalyses of patients with limited disease, extensive disease, histologic confirmation of fibrosing alveolitis, and with the reinclusion of patients with emphysema and pulmonary hypertension. The patterns of functional impairment were indicative of more severe ventilation-perfusion mismatch or anatomic shunting in CFA after adjustment for disease extent; we speculate that perfusion of poorly ventilated lung parenchyma in CFA occurs through new vessels formed in areas of intense inflammation. This mechanism may contribute to the greater mortality of patients with CFA than of patients with FASSc because of the deleterious effects of hypoxia on concurrent cardiac disease.

This article has been cited by other articles:

				A E Holland, C J Hill, M Conron, P Munro, and C F McDonald Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease Thorax, June 1, 2008; 63(6): 549 - 554. [Abstract] [Full Text] [PDF]

				K. P. Sylvester, S. R. Desai, A. U. Wells, D. M. Hansell, M. Awogbade, S. L. Thein, and A. Greenough Computed tomography and pulmonary function abnormalities in sickle cell disease Eur. Respir. J., October 1, 2006; 28(4): 832 - 838. [Abstract] [Full Text] [PDF]

				S. R. Desai, S. Veeraraghavan, D. M. Hansell, A. Nikolakopolou, N. S. L. Goh, A. G. Nicholson, T. V. Colby, C. P. Denton, C. M. Black, R. M. du Bois, et al. CT Features of Lung Disease in Patients with Systemic Sclerosis: Comparison with Idiopathic Pulmonary Fibrosis and Nonspecific Interstitial Pneumonia Radiology, August 1, 2004; 232(2): 560 - 567. [Abstract] [Full Text] [PDF]

				E. A. Renzoni Neovascularization in Idiopathic Pulmonary Fibrosis: Too Much or too Little? Am. J. Respir. Crit. Care Med., June 1, 2004; 169(11): 1179 - 1180. [Full Text] [PDF]

				D D Smith, Y C G. Lee, B Singh, S C Pang, N H de Klerk, D R Hillman, and A W Musk Earlier study on asbestos workers, ILO scores, and oxygenation more comprehensive * Authors' reply Occup. Environ. Med., August 1, 2003; 60(8): 611 - 611. [Full Text] [PDF]

				A. U. Wells, S. R. Desai, M. B. Rubens, N. S. L. Goh, D. Cramer, A. G. Nicholson, T. V. Colby, R. M. du Bois, and D. M. Hansell Idiopathic Pulmonary Fibrosis: A Composite Physiologic Index Derived from Disease Extent Observed by Computed Tomography Am. J. Respir. Crit. Care Med., April 1, 2003; 167(7): 962 - 969. [Abstract] [Full Text] [PDF]

				V. Saravanan and C. A. Kelly Survival in fibrosing alveolitis associated with rheumatoid arthritis is better than cryptogenic fibrosing alveolitis Rheumatology, April 1, 2003; 42(4): 603 - 604. [Full Text] [PDF]

				Y C G Lee, B Singh, S C Pang, N H de Klerk, D R Hillman, and A W Musk Radiographic (ILO) readings predict arterial oxygen desaturation during exercise in subjects with asbestosis Occup. Environ. Med., March 1, 2003; 60(3): 201 - 206. [Abstract] [Full Text] [PDF]

				E. A. Renzoni, D. A. Walsh, M. Salmon, A. U. Wells, P. Sestini, A. G. Nicholson, S. Veeraraghavan, A. E. Bishop, H. M. Romanska, P. Pantelidis, et al. Interstitial Vascularity in Fibrosing Alveolitis Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 438 - 443. [Abstract] [Full Text] [PDF]

				ATS/ACCP Statement on Cardiopulmonary Exercise Testing Am. J. Respir. Crit. Care Med., January 15, 2003; 167(2): 211 - 277. [Full Text] [PDF]

				J Fujita, T Yoshinouchi, Y Ohtsuki, M Tokuda, Y Yang, I Yamadori, S Bandoh, T Ishida, J Takahara, and R Ueda Non-specific interstitial pneumonia as pulmonary involvement of systemic sclerosis Ann Rheum Dis, March 1, 2001; 60(3): 281 - 283. [Abstract] [Full Text] [PDF]

				M. Selman, T. E. King Jr., and A. Pardo Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy Ann Intern Med, January 16, 2001; 134(2): 136 - 151. [Abstract] [Full Text] [PDF]

				C. Strange, M. Bolster, J. Mazur, M. Taylor, J. R. Gossage, and R. Silver Hemodynamic Effects of Epoprostenol in Patients With Systemic Sclerosis and Pulmonary Hypertension Chest, October 1, 2000; 118(4): 1077 - 1082. [Abstract] [Full Text] [PDF]

				T. King Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment . International Consensus Statement Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): 646 - 664. [Full Text]

				P. Paredi, S. A. Kharitonov, S. Loukides, P. Pantelidis, R. M. d. Bois, and P. J. Barnes Exhaled Nitric Oxide Is Increased in Active Fibrosing Alveolitis Chest, May 1, 1999; 115(5): 1352 - 1356. [Abstract] [Full Text] [PDF]

				P. MONTUSCHI, G. C. TONI, P. PAREDI, P. PANTELIDIS, R. M. du BOIS, S. A. KHARITONOV, and P. J. BARNES 8-Isoprostane as a Biomarker of Oxidative Stress in Interstitial Lung Diseases Am. J. Respir. Crit. Care Med., November 1, 1998; 158(5): 1524 - 1527. [Abstract] [Full Text] [PDF]